Acute respiratory distress syndrome associated with coronavirus infection is related to a
cytokine storm with large interleukin‐6 (IL‐6) release. The IL‐6‐receptor blocker tocilizumab …

ABSTRACT SARS-CoV-2 has claimed 2,137,908 lives in more than a year. Some COVID-19
patients experience sudden and rapid deterioration with the onset of fatal cytokine storm …

The outbreak of COVID-19 reminds us that the emerging and reemerging respiratory virus
infections pose a continuing threat to human life. Cytokine storm syndromes of viral origin …

Objective The pandemic of coronavirus disease (COVID-19) has rapidly spread globally and
infected millions of people. The prevalence and prognostic impact of dysnatremia in COVID …

Background In COVID-19 patients the progressive clinical deterioration seems secondary to
the activation of a cytokine storm. Ferritin is considered a direct mediator of the immune …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected billions and
has killed millions to date. Studies are being carried out to find therapeutic molecules that …

Clinical Trial Registration www. ClinicalTrials. gov, identifier: NCT04365634. Context
Diabetes mellitus was associated with increased severity and mortality of disease in COVID …

Objective. People who are exposed to severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) could develop a potentially fatal disease with lung involvement and severe …

One of the hallmarks of COVID-19 is the cytokine storm that provokes primarily pneumonia
followed by systemic inflammation. Emerging evidence has identified a potential link …

From the introduction of hyperferritinemic syndrome concept, a growing body of evidence
has suggested the role of ferritin as a pathogenic mediator and a relevant clinical feature in …